Aberdeen Group’s BeOne Medicines Ltd. American Depositary Shares ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14,913
| Closed | -$2.75M | – | 970 |
|
|
2024
Q4 | $2.75M | Sell |
14,913
-13,006
| -47% | -$2.4M | 0.01% | 724 |
|
|
2024
Q3 | $6.27M | Sell |
27,919
-5,149
| -16% | -$1.16M | 0.01% | 614 |
|
|
2024
Q2 | $4.72M | Buy |
33,068
+11,930
| +56% | +$1.7M | 0.01% | 635 |
|
|
2024
Q1 | $3.31M | Hold |
21,138
| – | – | 0.01% | 727 |
|
|
2023
Q4 | $3.81M | Buy |
21,138
+19,677
| +1,347% | +$3.55M | 0.01% | 714 |
|
|
2023
Q3 | $263K | Hold |
1,461
| – | – | ﹤0.01% | 861 |
|
|
2023
Q2 | $260K | Hold |
1,461
| – | – | ﹤0.01% | 886 |
|
|
2023
Q1 | $315K | Hold |
1,461
| – | – | ﹤0.01% | 870 |
|
|
2022
Q4 | $321K | Sell |
1,461
-11,394
| -89% | -$2.51M | ﹤0.01% | 866 |
|
|
2022
Q3 | $1.73M | Buy |
12,855
+2,345
| +22% | +$316K | 0.01% | 728 |
|
|
2022
Q2 | $1.7M | Buy |
10,510
+6,018
| +134% | +$974K | 0.01% | 732 |
|
|
2022
Q1 | $847K | Sell |
4,492
-49
| -1% | -$9.24K | ﹤0.01% | 843 |
|
|
2021
Q4 | $1.23M | Buy |
4,541
+306
| +7% | +$82.9K | ﹤0.01% | 848 |
|
|
2021
Q3 | $1.54M | Buy |
4,235
+230
| +6% | +$83.5K | ﹤0.01% | 831 |
|
|
2021
Q2 | $1.37M | Buy |
4,005
+44
| +1% | +$15.1K | ﹤0.01% | 832 |
|
|
2021
Q1 | $1.38M | Buy |
3,961
+915
| +30% | +$319K | ﹤0.01% | 822 |
|
|
2020
Q4 | $787K | Sell |
3,046
-11,360
| -79% | -$2.94M | ﹤0.01% | 852 |
|
|
2020
Q3 | $4.13M | Buy |
14,406
+1,106
| +8% | +$317K | 0.01% | 591 |
|
|
2020
Q2 | $2.51M | Buy |
13,300
+180
| +1% | +$33.9K | 0.01% | 668 |
|
|
2020
Q1 | $1.62M | Buy |
13,120
+881
| +7% | +$108K | 0.01% | 699 |
|
|
2019
Q4 | $2.03M | Sell |
12,239
-2,282
| -16% | -$378K | ﹤0.01% | 722 |
|
|
2019
Q3 | $1.78M | Buy |
14,521
+3,300
| +29% | +$405K | ﹤0.01% | 730 |
|
|
2019
Q2 | $1.39M | Buy |
11,221
+900
| +9% | +$112K | ﹤0.01% | 789 |
|
|
2019
Q1 | $1.36M | Sell |
10,321
-188
| -2% | -$24.8K | ﹤0.01% | 774 |
|
|
2018
Q4 | $1.45M | Buy |
+10,509
| New | +$1.45M | ﹤0.01% | 727 |
|